Evaluation of vinorelbine (N) and trastuzumab (H) as first-line therapy for patients (pts) with HER2- positive metastatic breast cancer (HER2+ MBC): Impact on clinical response and cardiac function
Year: 2004
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: V. Guillem Porta, M. Martin, M. Gil Gil, P. Kellokumpu-Lehtinen, F. Majois, J. Gasmi, D. Aubert, O. Bourrillon
Language: English
Topic: HER2/EGFR in Cancer Research
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2245229130